Validation of a patient satisfaction questionnaire for anemia treatment, the PSQ-An
Open Access
- 3 May 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Health and Quality of Life Outcomes
- Vol. 4 (1), 1-10
- https://doi.org/10.1186/1477-7525-4-28
Abstract
Background: Treating anemia associated with chemotherapy and many cancers is often necessary. However, patient satisfaction with anemia treatment is limited by the lack of validated instruments. We developed and validated a new treatment-specific patient satisfaction instrument: the Patient Satisfaction Questionnaire for Anemia Treatment (PSQ-An). Treatment burden and overall satisfaction scales were designed for ease of use in clinical practice. Methods: 312 cancer patients (141 breast, 69 gynecological, and 102 non-small cell lung) were targeted to complete the PSQ-An at 4 week intervals. Data from weeks 5 and 9 were analyzed. Patients also completed the MOS SF-36 Global Health assessment and questions concerning resources devoted to anemia treatment. Item reduction used endorsement rates, floor/ceiling effects, and item-item correlations. Factor analysis identified meaningful subscales. Test-retest reliability was assessed. Construct validity was tested, using Pearson's correlations, by comparing subscale scores to Global Health, hemoglobin levels, and resources devoted to anemia treatment. Results: The overall response rate was 92.9% (264/284) at week 5. Most (84.2%) of the patients were female, and the mean (SD) age was 60.2 (± 11.8) years. Two distinct subscales were identified measuring treatment burden (7 items) and overall satisfaction (2 items). Test-retest reliability was examined (ICC: 0.45–0.67); both were internally consistent (alpha = 0.83). Both subscales exhibited convergent and divergent validity with independent measures of health. ANOVA results indicated that the PSQ-An Satisfaction subscale discriminated between 5 levels of MOS SF-36 Global Health (P = 0.006). Conclusion: The PSQ-An is a validated, treatment-specific instrument for measuring satisfaction with anemia treatment for cancer patients. PSQ-An subscales reflect the burden of injection anemia treatment on cancer patients and their assessment of the overall treatment value.Keywords
This publication has 34 references indexed in Scilit:
- Satisfaction with Medication: An Overview of Conceptual, Methodologic, and Regulatory IssuesValue in Health, 2004
- Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective surveyEuropean Journal Of Cancer, 2001
- Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes.Diabetes Care, 2000
- Radiotherapy-Associated Anemia: The Scope of the ProblemThe Oncologist, 2000
- Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapyCancer, 1995
- Recombinant Human Erythropoietin in the Treatment of Cancer-Related AnaemiaOncology, 1994
- Measuring health status: What are the necessary measurement properties?Journal of Clinical Epidemiology, 1992
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- A Method for Correcting Item-Total Correlations for the Effect of Relevant Item InclusionEducational and Psychological Measurement, 1962
- Convergent and discriminant validation by the multitrait-multimethod matrix.Psychological Bulletin, 1959